Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
NANO > SEC Filings for NANO > Form 8-K on 8-Aug-2014All Recent SEC Filings

Show all filings for NANOMETRICS INC



Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 4, 2014, Ronald W. Kisling, Chief Financial Officer of Nanometrics Incorporated, advised Nanometrics that he would be resigning as Chief Financial Officer of the company, effective August 29, 2014, to accept a new job opportunity.

Upon Mr. Kisling's departure, Dr. Timothy J. Stultz, President and Chief Executive Officer, will assume the role of principal financial and accounting officer until a new Chief Financial Officer is appointed. Mr. Kisling will continue to direct the company's finance organization until his departure date, and will assist with the transition.

Dr. Stultz will not receive any additional compensation as interim principal financial and accounting officer. Dr. Stultz's compensation arrangements as President and Chief Executive Officer are described in Nanometrics' proxy statement, filed with the Securities and Exchange Commission on April 7, 2014.

Dr. Stultz, 66, has served as Nanometrics' President, Chief Executive Officer and a director since August 2007. From June 2003 to August 2007, Dr. Stultz served as the president and chief executive officer and a director of Imago Scientific Instruments Corporation, a supplier of proprietary 3-D atom probe microscopes to the research materials and microelectronics industries. Prior to Imago, Dr. Stultz served as president and chief executive officer for ThauMDx, a developer of diagnostic systems and technologies for the analysis of biomolecules, drugs and chemicals. Dr. Stultz also serves on the Board of Directors of Tessera Technologies, Inc. Dr. Stultz received his B.S., M.S. and Ph.D. degrees in Materials Science and Engineering from Stanford University.

Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


/S/ Ronald W. Kisling
Ronald W. Kisling
Chief Financial Officer
Duly Authorized Officer

  Add NANO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for NANO - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.